| Primary |
| Dry Eye |
66.7% |
| Product Used For Unknown Indication |
16.4% |
| Drug Use For Unknown Indication |
5.6% |
| Hypertension |
2.1% |
| Glaucoma |
1.8% |
| Hypothyroidism |
0.8% |
| Postoperative Care |
0.7% |
| Eye Irritation |
0.7% |
| Sjogren's Syndrome |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Eye Inflammation |
0.5% |
| Blepharitis |
0.4% |
| Diabetes Mellitus |
0.4% |
| Hypersensitivity |
0.4% |
| Seasonal Allergy |
0.4% |
| Keratoconjunctivitis Sicca |
0.3% |
| Prophylaxis Against Graft Versus Host Disease |
0.3% |
| Lacrimal Disorder |
0.3% |
| Blood Pressure |
0.3% |
|
| Eye Irritation |
29.9% |
| Vision Blurred |
15.3% |
| Ocular Hyperaemia |
10.5% |
| Eye Pain |
7.7% |
| Drug Ineffective |
6.0% |
| Lacrimation Increased |
4.8% |
| Foreign Body Sensation In Eyes |
4.3% |
| Eye Pruritus |
3.4% |
| Headache |
2.6% |
| Dry Eye |
1.7% |
| Rash |
1.7% |
| Dizziness |
1.6% |
| Eye Discharge |
1.6% |
| Photophobia |
1.5% |
| Visual Acuity Reduced |
1.4% |
| Instillation Site Pain |
1.3% |
| Burning Sensation |
1.3% |
| Superficial Injury Of Eye |
1.3% |
| Eye Swelling |
1.2% |
| Eyelid Oedema |
1.1% |
|
| Secondary |
| Dry Eye |
49.2% |
| Product Used For Unknown Indication |
9.0% |
| Eye Irritation |
5.7% |
| Drug Use For Unknown Indication |
5.4% |
| Blepharitis |
3.2% |
| Hypertension |
2.8% |
| Postoperative Care |
2.6% |
| Glaucoma |
2.3% |
| Eye Inflammation |
2.1% |
| Foreign Body Sensation In Eyes |
2.0% |
| Corneal Disorder |
1.8% |
| Keratitis |
1.8% |
| Eye Discharge |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Keratoconjunctivitis Sicca |
1.7% |
| Corneal Erosion |
1.5% |
| Atrial Fibrillation |
1.4% |
| Eye Pain |
1.4% |
| Growth Of Eyelashes |
1.4% |
| Lacrimal Disorder |
1.4% |
|
| Eye Irritation |
17.9% |
| Vision Blurred |
15.1% |
| Eye Pain |
8.4% |
| Ocular Hyperaemia |
6.1% |
| Drug Ineffective |
5.6% |
| Foreign Body Sensation In Eyes |
5.0% |
| Photophobia |
5.0% |
| Superficial Injury Of Eye |
5.0% |
| Lacrimation Increased |
4.5% |
| Visual Acuity Reduced |
4.5% |
| Keratitis |
3.9% |
| Madarosis |
3.4% |
| Lichen Planus |
2.8% |
| Ulcerative Keratitis |
2.8% |
| Death |
1.7% |
| Dyspnoea |
1.7% |
| Localised Infection |
1.7% |
| Optic Neuritis |
1.7% |
| Rash |
1.7% |
| Tinnitus |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.0% |
| Dry Eye |
9.1% |
| Drug Use For Unknown Indication |
8.0% |
| Rheumatoid Arthritis |
7.7% |
| Pain |
4.4% |
| Hypertension |
3.6% |
| Asthma |
3.3% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Osteoporosis |
3.1% |
| Depression |
2.8% |
| Anxiety |
2.1% |
| Hypothyroidism |
2.1% |
| Insomnia |
1.8% |
| Vitamin Supplementation |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Multiple Sclerosis |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Migraine |
1.5% |
| Hypersensitivity |
1.5% |
| Crohn's Disease |
1.4% |
|
| Vomiting |
11.3% |
| Drug Ineffective |
7.5% |
| Weight Decreased |
7.5% |
| Vision Blurred |
6.5% |
| Nausea |
5.9% |
| Injection Site Pain |
5.4% |
| Rash |
5.0% |
| Pain In Extremity |
4.6% |
| Visual Acuity Reduced |
4.6% |
| Wrong Technique In Drug Usage Process |
4.6% |
| Sinusitis |
4.2% |
| Urinary Tract Infection |
4.2% |
| Weight Increased |
4.2% |
| Pain |
4.0% |
| Pruritus |
4.0% |
| Pneumonia |
3.6% |
| Pyrexia |
3.3% |
| Tremor |
3.3% |
| Headache |
3.1% |
| Product Quality Issue |
3.1% |
|
| Interacting |
| Dry Eye |
22.7% |
| Blood Cholesterol Increased |
13.6% |
| Blood Triglycerides Increased |
9.1% |
| Hypertension |
9.1% |
| Back Pain |
4.5% |
| Chronic Myeloid Leukaemia |
4.5% |
| Encephalopathy |
4.5% |
| Eye Disorder |
4.5% |
| Herpes Simplex |
4.5% |
| Osteoporosis |
4.5% |
| Product Used For Unknown Indication |
4.5% |
| Pulse Abnormal |
4.5% |
| Rhinorrhoea |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
|
| Drug Interaction |
33.3% |
| Haemolytic Anaemia |
11.1% |
| Localised Infection |
11.1% |
| Myalgia |
11.1% |
| Urine Abnormality |
11.1% |
| Vertigo |
11.1% |
| Vomiting |
11.1% |
|
